Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
A study illuminates the alcohol consumption habits of cancer survivors.
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he’ll be remembered.
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
A study shows that some cancer patients wish they had known more about possible adverse effects of treatment.
Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.
The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.
Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.
Handle With Care
donate to the AACR
The AACR Cancer Progress Report 2019, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.